Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Dis Colon Rectum. 2019 May;62(5):586–594. doi: 10.1097/DCR.0000000000001342

Table 3.

Sex differences in ulcerative colitis medication prescription during follow-up period

N=Have Ever Taken During Enrollment (%) Overall (n=38,851) Male (n=18,489) Female (n=20,362) p-value
Steroids 21,289 (54.8) 9,982 (54.0) 11,307 (55.5) 0.002
Immunomodulators 6,039 (15.5) 3,013 (16.3) 3,026 (14.9) <0.001
Biologics 4,372(11.2) 2,298 (12.4) 2,074 (10.2) <0.001
5-ASA 25,251 (65.0) 12,380 (67.0) 12,871 (63.2) <0.001
Opioids 18,707 (48.2) 8,479 (45.9) 10,228 (50.2) <0.001